171 related articles for article (PubMed ID: 8529076)
21. Immunoreactive endogenous ouabain in primary aldosteronism and essential hypertension: relationship with plasma renin, aldosterone and blood pressure levels.
Rossi G; Manunta P; Hamlyn JM; Pavan E; De Toni R; Semplicini A; Pessina AC
J Hypertens; 1995 Oct; 13(10):1181-91. PubMed ID: 8586810
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of a test using saralasin to differentiate primary aldosteronism due to an aldosterone-producing adenoma from idiopathic hyperaldosteronism.
Brown RD; Kem DC; Hogan MJ; Hegstad RL
Metabolism; 1984 Aug; 33(8):734-8. PubMed ID: 6748946
[TBL] [Abstract][Full Text] [Related]
23. A reverse postural test as a screening tool for aldosterone-producing adenoma: a pilot study.
Weickert MO; Schöfl-Siegert B; Arafat AM; Pfeiffer AF; Möhlig M; Schöfl C
Endocrine; 2009 Aug; 36(1):75-82. PubMed ID: 19399649
[TBL] [Abstract][Full Text] [Related]
24. Nocturnal, daytime, and postural changes of plasma aldosterone before and during dexamethasone in adenomatous and idiopathic aldosteronism.
Hoefnagels WH; Drayer JI; Smals AG; Benraad TJ; Kloppenborg PW
J Clin Endocrinol Metab; 1980 Dec; 51(6):1330-4. PubMed ID: 7440698
[TBL] [Abstract][Full Text] [Related]
25. Escape from the sodium-retaining effects of mineralocorticoids: is there a role for dopamine?
Coruzzi P
J Clin Endocrinol Metab; 1994 Feb; 78(2):455-8. PubMed ID: 8106635
[TBL] [Abstract][Full Text] [Related]
26. Decreased plasma prorenin levels in primary aldosteronism: potential diagnostic implications.
Berge C; Courand PY; Harbaoui B; Paget V; Khettab F; Bricca G; Fauvel JP; Lantelme P
J Hypertens; 2015 Jan; 33(1):118-25. PubMed ID: 25333683
[TBL] [Abstract][Full Text] [Related]
27. Pressor and hormonal responses to intravenous injection of metoclopramide in normotensive and hypertensive patients.
Kawabe H; Suzuki H; Itaya Y; Saruta T
Jpn J Med; 1990; 29(2):174-9. PubMed ID: 2232366
[TBL] [Abstract][Full Text] [Related]
28. Urinary kallikrein excretion in patients with primary aldosteronism: differentiation of adrenal adenoma from idiopathic adrenal hyperplasia.
Nakada T
Urol Int; 1984; 39(1):40-5. PubMed ID: 6375065
[TBL] [Abstract][Full Text] [Related]
29. Dopamine reduces aldosterone and 18-hydroxycorticosterone response to angiotensin II in patients with essential low-renin hypertension and idiopathic hyperaldosteronism.
Witzgall H; Lorenz R; von Werder K; Weber PC
Clin Sci (Lond); 1985 Mar; 68(3):291-9. PubMed ID: 3882312
[TBL] [Abstract][Full Text] [Related]
30. Primary aldosteronism with bilateral multiple aldosterone-producing adrenal adenomas.
Matsuda A; Beniko M; Ikota A; Yamazaki M; Koizumi S; Mizumoto H; Watanabe T; Matsuya K; Kunita H; Mashio Y; Sasano H
Intern Med; 1996 Dec; 35(12):970-5. PubMed ID: 9030997
[TBL] [Abstract][Full Text] [Related]
31. [The effect of dopaminergic antagonists on plasma aldosterone in normal subjects and patients with hypopituitarism].
Shikuma R; Yoshimura M; Takashina R; Yamazaki H; Kambara S; Ijichi H
Nihon Naibunpi Gakkai Zasshi; 1984 Sep; 60(9):1041-5. PubMed ID: 6394371
[TBL] [Abstract][Full Text] [Related]
32. Correctable subsets of primary aldosteronism. Primary adrenal hyperplasia and renin responsive adenoma.
Irony I; Kater CE; Biglieri EG; Shackleton CH
Am J Hypertens; 1990 Jul; 3(7):576-82. PubMed ID: 2194512
[TBL] [Abstract][Full Text] [Related]
33. Remodeling of the left ventricle in primary aldosteronism due to Conn's adenoma.
Rossi GP; Sacchetto A; Pavan E; Palatini P; Graniero GR; Canali C; Pessina AC
Circulation; 1997 Mar; 95(6):1471-8. PubMed ID: 9118515
[TBL] [Abstract][Full Text] [Related]
34. Adrenalectomy improves increased carotid intima-media thickness and arterial stiffness in patients with aldosterone producing adenoma.
Lin YH; Lin LY; Chen A; Wu XM; Lee JK; Su TC; Wu VC; Chueh SC; Lin WC; Lo MT; Wang PC; Ho YL; Wu KD;
Atherosclerosis; 2012 Mar; 221(1):154-9. PubMed ID: 22197109
[TBL] [Abstract][Full Text] [Related]
35. Effect of aldosterone-producing adenoma on endothelial function and Rho-associated kinase activity in patients with primary aldosteronism.
Matsumoto T; Oki K; Kajikawa M; Nakashima A; Maruhashi T; Iwamoto Y; Iwamoto A; Oda N; Hidaka T; Kihara Y; Kohno N; Chayama K; Goto C; Aibara Y; Noma K; Liao JK; Higashi Y
Hypertension; 2015 Apr; 65(4):841-8. PubMed ID: 25624340
[TBL] [Abstract][Full Text] [Related]
36. Therapeutic value of calcium antagonists in autonomous hyperaldosteronism.
Stimpel M; Ivens K; Volkmann HP; Wambach G; Kaufmann W
Klin Wochenschr; 1989 Feb; 67(4):248-52. PubMed ID: 2648061
[TBL] [Abstract][Full Text] [Related]
37. Urinary aldosterone-to-active-renin ratio: a useful tool for predicting resolution of hypertension after adrenalectomy in patients with aldosterone-producing adenomas.
Mourad JJ; Girerd X; Milliez P; Lopez-Sublet M; Lejeune S; Safar ME
Am J Hypertens; 2008 Jul; 21(7):742-7. PubMed ID: 18443567
[TBL] [Abstract][Full Text] [Related]
38. Effects of naloxone on adrenal cortex regulation in patients with primary aldosteronism.
Fallo F; Boscaro M; Sonino N; Mantero F
J Endocrinol Invest; 1988 Apr; 11(4):261-5. PubMed ID: 2970500
[TBL] [Abstract][Full Text] [Related]
39. [The significance of atrial natriuretic polypeptide in the cause of essential hypertension].
Mori K
Nihon Naibunpi Gakkai Zasshi; 1991 Jul; 67(7):796-810. PubMed ID: 1653713
[TBL] [Abstract][Full Text] [Related]
40. [Clinical Characteristics of Aldosterone Producing Adenoma and Idiopathic Hyperaldosteronism with Obstructive Sleep Apnea Hypopnea Syndrome].
Zuo FJ; Zhou XH; Ren Y; Chen T; Tian HM
Sichuan Da Xue Xue Bao Yi Xue Ban; 2020 May; 51(3):298-303. PubMed ID: 32543133
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
